1
|
Campbell MLH, McNamee MJ. Ethics, Genetic Technologies and Equine Sports: The Prospect of Regulation of a Modified Therapeutic Use Exemption Policy. SPORT ETHICS AND PHILOSOPHY 2020. [DOI: 10.1080/17511321.2020.1737204] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- M. L. H Campbell
- Department of Production and Population Sciences, The Royal Veterinary College, South Mymms, UK
| | - M. J. McNamee
- School of Sport and Exercise Sciences, Swansea University, Swansea, UK
- Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven, Leuven, Belgium
| |
Collapse
|
2
|
Garrett JR, Lantos JD, Biesecker LG, Childerhose JE, Chung WK, Holm IA, Koenig BA, McEwen JE, Wilfond BS, Brothers K. Rethinking the "open future" argument against predictive genetic testing of children. Genet Med 2019; 21:2190-2198. [PMID: 30894702 PMCID: PMC6754817 DOI: 10.1038/s41436-019-0483-4] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Accepted: 02/27/2019] [Indexed: 02/07/2023] Open
Abstract
Professional consensus has traditionally discouraged predictive genetic testing when no childhood interventions can reduce future morbidity or mortality. However, advances in genome sequencing and accumulating evidence that children and families cope adequately with predictive genetic information have weakened this consensus. The primary argument remaining against testing appeals to children's "right to an open future." It claims that the autonomy of the future adult is violated when others make an irreversible choice to obtain or disclose predictive genetic information during childhood. We evaluate this argument and conclude that children's interest in an open future should not be understood as a right. Rather an open future is one significant interest to weigh against other important interests when evaluating decisions. Thus, predictive genetic testing is ethically permissible in principle, as long as the interests promoted outweigh potential harms. We conclude by offering an expanded model of children's interests that might be considered in such circumstances, and present two case analyses to illustrate how this framework better guides decisions about predictive genetic testing in pediatrics.
Collapse
Affiliation(s)
- Jeremy R Garrett
- Children's Mercy Bioethics Center, Children's Mercy Kansas City, Kansas City, MO, USA.
- Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO, USA.
| | - John D Lantos
- Children's Mercy Bioethics Center, Children's Mercy Kansas City, Kansas City, MO, USA
- Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO, USA
| | - Leslie G Biesecker
- National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Janet E Childerhose
- Division of Pediatric Clinical and Translational Research, University of Louisville School of Medicine, Louisville, KY, USA
| | - Wendy K Chung
- Departments of Medicine and Pediatrics, Columbia University, New York, NY, USA
| | - Ingrid A Holm
- Division of Genetics and Genomics and the Manton Center for Orphan Diseases Research, and Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA
| | - Barbara A Koenig
- UCSF Bioethics, University of California San Francisco, San Francisco, CA, USA
| | - Jean E McEwen
- National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Benjamin S Wilfond
- Treuman Katz Bioethics Center, Seattle Children's Research Institute, Seattle, WA, USA
- Department of Pediatrics, University of Washington, Seattle, WA, USA
| | - Kyle Brothers
- Department of Pediatrics, University of Louisville, Louisville, KY, USA
| |
Collapse
|
3
|
Varley I, Patel S, Williams AG, Hennis PJ. The current use, and opinions of elite athletes and support staff in relation to genetic testing in elite sport within the UK. Biol Sport 2018; 35:13-19. [PMID: 30237657 PMCID: PMC6135972 DOI: 10.5114/biolsport.2018.70747] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Revised: 08/02/2017] [Accepted: 08/29/2017] [Indexed: 12/16/2022] Open
Abstract
The purpose of the study was to investigate the current use of genetic testing in UK elite sport and assess how genetic testing might be received by those employed in elite sport. Seventy-two elite athletes and 95 support staff at UK sports clubs and governing bodies completed an online survey of 11 questions concerning their experience of genetic testing and beliefs regarding the use of genetic testing in sport. Genetic testing related to sports performance and injury susceptibility is conducted in UK elite sport, albeit by a relatively small proportion of athletes (≤17%) and support staff (≤8%). Athletes and their support staff agree that genetics are important in determining elite status (≥79%) and appear willing to engage in genetic testing for individualising training to improve sport performance and reduce injury risk. Opinion was divided on whether genetic information should be used to identify talented athletes and influence selection, eligibility or employment status. Genetic testing for sports performance and injury susceptibility occurs in UK elite sport, however it is not commonly conducted. There is a belief that genetics is an important factor in determining an athlete and there is a willingness to engage in genetic testing for sports performance and injury susceptibility.
Collapse
Affiliation(s)
- Ian Varley
- Sport, Health and Performance Enhancement Research Centre, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS, UK
| | - Seema Patel
- Centre for Sports Law, Nottingham Law School, Nottingham Trent University, Goldsmith Street, Nottingham, NG1 5LP, UK
| | - Alun G. Williams
- Sports Genomics Laboratory, Department of Exercise and Sport Science, Manchester Metropolitan University, Crewe Green Road, Crewe, CW1 5DU, UK
| | - Philip J. Hennis
- Centre for Health, Exercise & Active Living (HEAL), Department of Exercise and Sport Science, Manchester Metropolitan University, Crewe Green Road, Crewe, CW1 5DU, UK
| |
Collapse
|
4
|
Searching for the elusive gift: advances in talent identification in sport. Curr Opin Psychol 2017; 16:128-133. [DOI: 10.1016/j.copsyc.2017.04.016] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2017] [Accepted: 04/15/2017] [Indexed: 11/23/2022]
|
5
|
Vlahovich N, Fricker PA, Brown MA, Hughes D. Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport. Br J Sports Med 2016; 51:5-11. [PMID: 27899345 PMCID: PMC5256128 DOI: 10.1136/bjsports-2016-096661] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/07/2016] [Indexed: 01/02/2023]
Abstract
As Australia's peak high-performance sport agency, the Australian Institute of Sport (AIS) has developed this position statement to address the implications of recent advances in the field of genetics and the ramifications for the health and well-being of athletes. Genetic testing has proven of value in the practice of clinical medicine. There are, however, currently no scientific grounds for the use of genetic testing for athletic performance improvement, sport selection or talent identification. Athletes and coaches should be discouraged from using direct-to-consumer genetic testing because of its lack of validation and replicability and the lack of involvement of a medical practitioner in the process. The transfer of genetic material or genetic modification of cells for performance enhancement is gene doping and should not be used on athletes. There are, however, valid roles for genetic research and the AIS supports genetic research which aims to enhance understanding of athlete susceptibility to injury or illness. Genetic research is only to be conducted after careful consideration of a range of ethical concerns which include the provision of adequate informed consent. The AIS is committed to providing leadership in delivering an ethical framework that protects the well-being of athletes and the integrity of sport, in the rapidly changing world of genomic science.
Collapse
Affiliation(s)
- Nicole Vlahovich
- Department of Sports Medicine, Australian Institute of Sport, Bruce, Australian Capital Territory, Australia.,CRN for Advancing Exercise and Sport Science, Bond University, University Drive, Robina, Queensland, Australia
| | - Peter A Fricker
- Research Institute for Sport and Exercise, University of Canberra, University Drive, Bruce, Australian Capital Territory, Australia
| | - Matthew A Brown
- Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia
| | - David Hughes
- Department of Sports Medicine, Australian Institute of Sport, Bruce, Australian Capital Territory, Australia
| |
Collapse
|